Type here to filter the list

Thursday, May 29th
9:30 AM - 10:30 AM East Coast USA Time
Exploring Expanded Access: Balancing Patient Needs and Regulatory Considerations
Location: Woodrow Wilson
Chair: Mariam Ahmed, PharmD, PhD (she/her/hers) – Takeda
Speaker: Mira (Mitze) Klingenberg, RN (she/her/hers) – Voices for ALS
Speaker: Mwango Kashoki, MD, MPH – Parexel International
Speaker: Indranil Bhattacharya, PhD (he/him/his) – Takeda
Rare Diseases (RD)Oncology (ONC)
Friday, May 30th
11:00 AM - 12:00 PM East Coast USA Time
Optimizing Dose Selection for Bispecifics: Lessons Learned
Location: National Harbor 3
Chair: Ahmed A. Othman, PhD – Exelixis, Inc.
Chair: Mohamed-Eslam Mohamed, PhD, RPh – AbbVie
Speaker: Priyanka Madia, PhD – Gilead Sciences
Speaker: Jason H. Williams, PhD – Exelixis
Speaker: Tommy R. Li, PhD – Genmab
Oncology (ONC)Biologics (BIO)
Friday, May 30th
3:00 PM - 4:00 PM East Coast USA Time
Dose-Optimization in Oncology: Identifying Gaps and Opportunities
Location: National Harbor 3
Chair: Ya-Feng Wen, PharmD, PhD (he/him/his) – Gilead Sciences
Speaker: Naveen Mangal, PhD (he/him/his) – Merck
Speaker: Karthik Venkatakrishnan, PhD – EMD Serono
Speaker: Jeffrey A. Moscow, MD (he/him/his) – Investigational Drug Branch, National Cancer Institute
Speaker: Olanrewaju O. Okusanya, MS, PharmD (he/him/his) – US Food and Drug Administration
Oncology (ONC)